This finding has implications for a wide variety of oncologic disease processes, as PRMT5 has been implicated in the pathogenesis of lung adenocarcinoma, lung squamous cell carcinoma, breast cancers, colorectal cancer, and gastric cancer [93,94,95]. Here, PRMT5 is linked to colorectal cancer.